Health ❯Healthcare
Infectious Diseases Public Health Infectious Diseases Epidemiology Pharmaceuticals Clinical Trials Microbiology Epidemiology Disease Prevention Research
The panel's unanimous vote coincides with new FDA policies restricting booster eligibility for healthy individuals under 65 without additional trials.